Skip to main content
Knowledge Base
for the National TB Elimination Program - NTEP
Main navigation
Home
About Us
Curriculum
Search Courses
Knowledge Map
Knowledge Map Summary
Page Library
Content Page Summary
Translations
Documents
Select your language
English
Hindi
Tamil
Gujarati
Marathi
Telugu
Oriya
Search
Search
Final Review
Home
Final Review
Content Status at the final stage of review before it is approved for use.
DAIDS scale for assessment of Peripheral Neuropathy
H5Content
Rationale for continuation of Moxifloxacin in BPaLM regimen irrespective of FQ resistance
H5Content
Newer Anti-TB Drugs: Pretomanid [Pa]
H5Content
Relative contraindications Criteria for BPaLM
H5Content
BPaLM regimen for DR-TB
H5Content
2024 NTEG Recommendations for DR-TB Management
H5Content
WHO recommendation for newer, shorter, oral regimens
H5Content
Eligibility Criteria for BPaLM
H5Content
DR-TB Treatment – Patient Flow
H5Content
Planning Process at TU level
H5Content
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Subscribe to Final Review